PDCD1 and sarcoidosis: Though it is generally accepted that Th1 cells are involved in the pathogenesis of sarcoidosis [1], Lomax et al. proposed that sarcoidosis may develop when Th17.1 cells, which co-produce IFN-γ and IL-17, are amplified by anti-PD-1 immunotherapy [16].